Parag Garhyan Selected Research

basal insulin peglispro

1/2018	Basal insulin peglispro increases lipid oxidation, metabolic flexibility, thermogenesis and ketone bodies compared to insulin glargine in subjects with type 1 diabetes mellitus.
1/2018	Attenuated suppression of lipolysis explains the increases in triglyceride secretion and concentration associated with basal insulin peglispro relative to insulin glargine treatment in patients with type 1 diabetes.
1/2017	Hypoglycemia Risk Related to Double Dose Is Markedly Reduced with Basal Insulin Peglispro Versus Insulin Glargine in Patients with Type 2 Diabetes Mellitus in a Randomized Trial: IMAGINE 8.
1/2017	Novel hepato-preferential basal insulin peglispro (BIL) does not differentially affect insulin sensitivity compared with insulin glargine in patients with type 1 and type 2 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Parag Garhyan Research Topics

Disease

10	Type 2 Diabetes Mellitus (MODY) 01/2021 - 07/2016
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2023 - 01/2017
3	Disease Progression 10/2023 - 01/2016
3	Hypoglycemia (Reactive Hypoglycemia) 05/2023 - 07/2016
2	Insulin Resistance 01/2021 - 01/2017
2	Weight Loss (Weight Reduction) 01/2021 - 01/2018
2	Hyperglycemia 01/2021 - 10/2018
2	Body Weight (Weight, Body) 01/2021 - 11/2017
1	Rare Diseases (Rare Disease) 10/2023
1	Vomiting 01/2023
1	Nausea 01/2023
1	Inflammation (Inflammations) 01/2021
1	Schizophrenia (Dementia Praecox) 01/2011

Drug/Important Bio-Agent (IBA)

9	Insulin (Novolin)FDA Link 01/2023 - 01/2017
7	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 07/2016
5	adomeglivantIBA 11/2017 - 07/2016
5	Glucagon Receptors (Glucagon Receptor)IBA 11/2017 - 07/2016
4	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2016
4	Insulin Glargine (Lantus)FDA Link 01/2018 - 01/2017
4	basal insulin peglisproIBA 01/2018 - 01/2017
2	Glucagon (Glukagon)FDA Link 05/2023 - 07/2016
2	Blood Glucose (Blood Sugar)IBA 10/2018 - 01/2017
2	LipidsIBA 01/2018 - 01/2018
1	Insulin Lispro (Humalog)FDA Link 01/2023
1	Meloxicam (Mobic)FDA LinkGeneric 01/2023
1	Phenol (Carbolic Acid)FDA Link 01/2021
1	3-cresol (m-cresol)IBA 01/2021
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 10/2018
1	Metformin (Glucophage)FDA LinkGeneric 10/2018
1	2,4-thiazolidinedione (thiazolidinedione)IBA 10/2018
1	Triglycerides (Triacylglycerol)IBA 01/2018
1	Nonesterified Fatty Acids (NEFA)IBA 01/2018
1	VLDL LipoproteinsIBA 01/2018
1	Ketone BodiesIBA 01/2018
1	CholesterolIBA 11/2017
1	Sitagliptin Phosphate (Januvia)FDA Link 11/2017
1	Olanzapine (Zyprexa)FDA Link 01/2011

Therapy/Procedure

1	Injections 01/2023
1	Operative Surgical Procedures 01/2021
1	Glycemic Control 10/2018
1	Therapeutics 10/2018